Ampio Pharmaceuticals Inc (NYSEAMERICAN:AMPE)’s share price gapped up prior to trading on Monday . The stock had previously closed at $1.25, but opened at $1.36. Ampio Pharmaceuticals shares last traded at $1.65, with a volume of 2154900 shares traded.

Separately, ValuEngine upgraded Ampio Pharmaceuticals from a “strong sell” rating to a “sell” rating in a report on Wednesday, October 11th.

TRADEMARK VIOLATION NOTICE: “Ampio Pharmaceuticals (AMPE) Shares Gap Up to $1.36” was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company’s two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema.

Receive News & Ratings for Ampio Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.